Abstract:Cytochrome P450scc (CYP11A1) can hydroxylate vitamin D3 producing 20S-hydroxyvitamin D3 [20(OH)D3] and 20S,23-dihydroxyvitamin D3 [20,23(OH)2D3] as the major metabolites. These are biologically active acting as partial vitamin D receptor [VDR] agonists. Minor products include 17-hydroxyvitamin D3, 17,20-dihydroxyvitamin D3 and 17,20,23trihydroxyvitamin D3. In the current study we have further analyzed the reaction products from P450scc action on vitamin D3 and have identified two 22-hydroxy-derivatives as products, 22hydroxyvitamin D3 [22(OH)D3] and 20S,22-dihydroxyvitamin D3 [20,22(OH)2D3]. The structures of both of these derivatives were determined by NMR. P450scc could convert purified 22(OH)D3 to 20,22(OH)2D3. The 20,22(OH)2D3 could also be produced from 20(OH)D3 and was metabolized to a trihydroxyvitamin D3 product. We compared the biological activities of these new derivatives to those of 20(OH)D3, 20,23(OH)2D3 and 1α,25-dihydroxyvitamin D3 [1,25(OH)2D3]. 1,25(OH)2D3, 20(OH)D3, 22(OH)D3, 20,23(OH)2D3 and 20,22(OH)2D3 significantly inhibited keratinocyte proliferation in a dose dependent manner. The strongest inducers of involucrin expression (a marker of keratinocyte differentiation) were 20,23(OH)2D3, 20,22(OH)2D3, 20(OH)D3 and 1,25(OH)2D3, with 22(OH)D3 having a heterogeneous effect. Little or no stimulation of CYP24 mRNA expression was observed for all the analogues tested except for 1,25(OH)2D3. All the compounds stimulated VDR translocation from the cytoplasm to the nucleus with 22(OH)D3 and 20,22(OH)2D3 having less effect than 1,25(OH)2D3 and 20(OH)D3. Thus we have identified 22(OH)D3 and 20,22(OH)2D3 as products of CYP11A1 action on vitamin D3 and shown that like 20(OH)D3 and 20,23(OH)2D3, they are active on keratinocytes via the VDR, however, showing a degree of phenotypic heterogeneity in comparison to other P450scc-derived hydroxy-metabolites of vitamin D3. DMD #40071 This article has not been copyedited and formatted. The final version may differ from this version. DMD Fast Forward. Published on June 15, 2011 as DOI: 10.1124/dmd.111.040071 at A PE T Jornals on M arch 6, 2022 dm d.aspurnals.org D ow nladed from

Vitamin D3 metabolites. II. Further syntheses of 25-hydroxycholesterol.

Investigation on the synthesis of 25-hydroxycholesterol.

Synthesis of 25-Hydroxy-provitamin D 3 by Direct Hydroxylation of Protected 7-Dehydrocholesterol

Investigation into the Synthesis of C-25 Oxysterols

In vivo production of novel vitamin D2 hydroxy-derivatives by human placentas, epidermal keratinocytes, Caco-2 colon cells and the adrenal gland.

26,27-Dihomo-1 alpha-hydroxy- and 26,27-dihomo-24-epi-1 alpha,25-dihydroxyvitamin D2 analogs that differ markedly in biological activity in vivo.

HPLC-tandem mass spectrometric method to characterize resveratrol metabolism in humans.

Ultra-high-performance Liquid Chromatography-Tandem Mass Spectrometry Analysis of Serum Metabolomic Characteristics in People with Different Vitamin D Levels

Sterol metabolism—XLVI. Synthesis of oxidized cholesterol fatty acyl esters

Synthesis and Biological Evaluation of Vitamin D3 Metabolite 20S,23s-Dihydroxyvitamin D3 and Its 23r Epimer

Chemical Synthesis and Biological Activities of 20S,24s/r-Dihydroxyvitamin D3 Epimers and Their 1Α-Hydroxyl Derivatives

4-Hydroxy-1α,25-Dihydroxyvitamin D3: Synthesis and Structure–Function Study

A Highly Stereoselective Synthesis of C-24 and C-25 Oxysterols from Desmosterol.

The Synthesis Of 19-Nor-1 Alpha, 25-Dihydroxy-22-Oxo-Vitamin D-3

Discovery and Structural Analysis of Metabolites of Vitamin D3 Lactones

Microsoft Word-31088317-file00

Effect of indomethacin on pulmonary vasomotor response in patients with mitral stenosis.

Total Synthesis of Biologically Active 20S-Hydroxyvitamin D3

Thermal denaturation of human haemoglobins.

Highly selective whole-cell 25-hydroxyvitamin D3 synthesis using molybdenum-dependent C25-steroid dehydrogenase and cyclodextrin recycling

Detection of novel CYP11A1-derived secosteroids in the human epidermis and serum and pig adrenal gland